Editorial: Carotid Revasculatization vs Best Medical Management in Symptomatic Carotid Artery Disease.

13.1%), less benefit was seen in the 50%–69% stenosis group.[ 1 ] Similar results were replicated in the European Carotid Surgery Trial (ECST) with benefit being seen as ARR of 11.6% in patients with symptomatic carotid arterial disease and prior minor stroke or transient ischemic attack (TIA).[ 2 ] Since the two studies used different imaging criteria, reanalysis of ECST based on the NASCET criteria revealed very similar benefits, namely, mild risk reduction with stenosis of 50%–69% (5.7%) and highly significant risk reduction in the 70%–99% group (21.2%), with no benefit in the near occlusion group.[ 3 ] Subsequent studies comparing CEA to carotid stenting (CS) (The Carotid Revascularization Endarterectomy vs.

also in 132,142 other papers